Less than a week into the second round of campaigning for the leadership of this post-Soviet nation, the Ukrainian election has come to resemble a reality show.
Volodymyr Zelensky, a comedian who won 30% of the vote in the first round of Ukraine's presidential election, laughs as he takes a blood test in Kiev, Ukraine, on Friday.
The challenger put the idea to Poroshenko in a slickly produced video challenging the incumbent to a debate before April 21, when voters go back to the polls to determine who will lead this nation of 43 million for the next five years. Poroshenko, whose campaign highlights his role as commander in chief against Moscow-backed separatists in the country’s war in the east, has criticized the comedian for lacking a clear policy agenda and political experience.
On Wednesday, Zelensky’s campaign followed up with a video challenging Poroshenko to a debate. The video showed the political newcomer confidently walking into the center of Kiev’s Olympic stadium, telling the president he would face him not as the “clown” Poroshenko has labeled him, but as a candidate for the presidency of Ukraine.
Poroshenko owns one of the country’s biggest networks, Channel 5. Zelensky’s popular television show, “Servant of the People,” and Kvartal 95, his comedy troupe, air on 1+1 Channel, which is owned by Ukrainian oligarch Ihor Kolomoysky.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Dispensed: Venture-backed insurance startup Bright Health's 2018 results, a dispute between 2 drug giants, and the quest for a male birth control drugDispensed: Venture-back insurance startup Bright Health's 2018 results, a dispute between 2 drug giants, and the quest for a male birth control drug
Lire la suite »
Ukraine presidential rivals undergo televised drug testsThe two remaining candidates in Ukraine's presidential race underwent telev...
Lire la suite »
FDA’s Gottlieb heads back to AEI to tackle drug pricesScott Gottlieb, the FDA commissioner who will step down Friday, plans to return to the American Enterprise Institute to write about and research drug prices.
Lire la suite »
With insulin price cap, drug industry is once again shamed into doing the right thingThe public and lawmakers have grown increasingly fed up with indefensibly high drug costs, and there’s a feeling among some policymakers that price controls should be on the table.
Lire la suite »
U.S. to wrap case against drug company executives tied to opioid crisisProsecutors on Thursday will present their closing arguments in the trial of the...
Lire la suite »
2 drug giants are feuding over a highly successful new migraine drug, and court documents reveal how profitable the $10 billion market could beTwo drugmakers, Amgen and Novartis, have worked together for years on a new type of cutting-edge migraine drug, Aimovig.
Lire la suite »
House committee passes bills to strengthen Obamacare and lower drug pricesHouse Democrats are taking their first steps to fulfill their promises to strengthen Obamacare and lower drug prices, as the fate of the Affordable Care Act promises to be a major 2020 election issue.
Lire la suite »
Drug company founder, execs exploited patients to sell opioid: U.S. prosecutorThe founder of Insys Therapeutics Inc put profits over patient safety by bribing...
Lire la suite »
Novartis, Amgen in dispute over migraine drug partnershipSwiss drugmaker Novartis AG sued Amgen Inc on Thursday, accusing the U.S. biotec...
Lire la suite »